Related Experiment Videos
[Huntington chorea. Animal models reveal new hypotheses for pathophysiology and therapy]
C M Kosinski1, J H Cha, A B Young
1Neurologische Klinik, Medizinische Fakultät der RWTH, Aachen.
Insights
Huntington's disease (HD) is a neurodegenerative disorder caused by gene mutations. Research highlights common mechanisms and the role of intranuclear inclusions and glutamate excitotoxicity in disease progression.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Context:
- Huntington's disease (HD) is a neurodegenerative disorder characterized by CAG-triplet repeat expansion in specific genes.
- Growing evidence suggests shared pathomechanisms across neurodegenerative diseases with similar genetic origins.
- Clinical presentations of these diseases can vary significantly despite common underlying genetic defects.
Purpose:
- To explore the common pathomechanisms in neurodegenerative diseases linked to CAG-triplet expansions.
- To investigate the role of intranuclear inclusion bodies in disease pathogenesis.
- To examine the connection between genetic defects and glutamate excitotoxicity in Huntington's disease.
Summary:
- CAG-triplet repeat expansions in genes cause a family of neurodegenerative diseases, including Huntington's disease (HD).
- Development of transgenic HD mouse models has revealed intranuclear inclusion bodies, offering insights into neurodegeneration mechanisms.
- Studies on these models suggest a link between the genetic defect and glutamate excitotoxicity in HD's neurodegenerative process.
Impact:
- Transgenic animal models are crucial for understanding HD pathogenesis.
- These models facilitate the accelerated development and testing of novel therapeutic strategies for Huntington's disease.
- Advancements in understanding HD mechanisms may benefit other related neurodegenerative disorders.
Abstract:
Huntington's disease (HD) is member of a growing family of neurodegenerative diseases which are caused by a CAG-Triplet expansion in the coding region of their respective genes. The results of the research of the last years is very suggestive of a common pathomechanisms of all these diseases even though their clinical appearance may be quite different. The development of new animal models by transferring the human gene defect into the mouse genome has led to the finding of so-called intranuclear inclusion bodies. This new observation allowed to come closer to solving the problem how this genetic defect causes neurodegeneration. Recent studies on transgenic HD mice could also demonstrate a possible connection between the genetic defect and glutamate exitotoxicity in the neurodegenerative process of HD which had been emphasized by earlier animal models of the disease. Transgenic animal models of HD will have an important impact on the understanding of the disease mechanisms and may contribute to a faster development and testing of new therapeutic approaches.